Invex Therapeutics Ltd News

Invex Therapeutics Ltd: Addendum to Notice of Annual General Meeting

Oct 17 09:27

Invex Therapeutics Ltd: Date of AGM and Closing Date for Director Nominations

Sep 23 14:22

Invex Therapeutics Ltd: Appendix 4G and Corporate Governance Statement

Aug 22 14:14

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 23 13:34

Invex Therapeutics Ltd: Final Director's Interest Notice

Jul 1 06:22

Invex Therapeutics Ltd: Invex receives R&D Tax Rebate

Jun 21 09:28

Invex Therapeutics Ltd: Details of Auditor Appointment/Resignation

Apr 19 11:43

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 12 12:49

Invex Therapeutics Ltd: Change of Director's Interest Notice

Apr 9 11:16

Invex Therapeutics Ltd: Change of Director's Interest Notice

Apr 3 08:16

Invex Therapeutics Ltd: Amendment to Appendix 3A.4

Mar 22 10:09

Invex Therapeutics Ltd: Update on R&D Tax Rebate from UK Government

Mar 5 07:26

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 11 12:50

Invex Therapeutics Ltd: Invex and Peptron Mutually Terminate Manufacturing Agreement

Dec 22, 2023 05:24

Invex Therapeutics Ltd: Chair's Address to Shareholders

Nov 28, 2023 10:42

Invex Therapeutics Ltd: Change of Director's Interest Notice x 3

Nov 27, 2023 17:08

Invex Therapeutics Ltd: Invex Granted European Patent for Exenatide in Hydrocephalus

Nov 22, 2023 05:14

Invex Therapeutics Ltd: Initial Director's Interest Notice

Nov 9, 2023 09:03

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 12, 2023 12:54

Invex Therapeutics Ltd: Date of AGM and Closing Date for Director Nominations

Sep 25, 2023 14:14